Osborne Partners Capital Management’s Quest Diagnostics DGX Stock Holding History

Osborne Partners Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.95M	Buy	+18,635	New	+$3.66M	0.22%	93

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Osborne Partners Capital Management's DGX Position: Q2 2026 in Review

Osborne Partners Capital Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 18,635 shares worth $3.95M. The stake represents 0.22% of the portfolio and ranks #93 among its holdings.

735 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Osborne Partners Capital Management held 18,635 shares of Quest Diagnostics worth $3.95M as of Q2 2026.
Quest Diagnostics was a new Osborne Partners Capital Management position in Q2 2026.
Quest Diagnostics made up 0.22% of Osborne Partners Capital Management's portfolio in Q2 2026, its #93 holding.
735 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Osborne Partners Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.